Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells

Shang Jie Wu, Shu Duan, Shui Ping Zhao, Ying Cai, Ping Chen, Xiang Fang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: To explore the effects of atorvastatin on expression of cyclooxygenase-2 (COX-2) in human pulmonary epithelial cells (A549). Methods: A549 cells were incubated in DMEM medium containing lipopolysaccharide (LPS) in the presence or absence of atorvastatin. After incubation, the medium was collected and the amount of prostaglandin E2 (PGE2) was measured by enzyme-linked immunosorbent assay (ELISA). The cells were harvested, and COX-2 mRNA and protein were analyzed by RT-PCR and western-blot respectively. Results: LPS increased the expression of COX-2 mRNA and production of PGE2 in a dose- and time-dependent manner in A549. Induction of COX-2 mRNA and protein by LPS were inhibited by atorvastatin in a dose-dependent manner. Atorvastatin also significantly decreased LPS-induced production of PGE2. There was a positive correlation between reduced of COX-2 mRNA and decreased of PGE2 (r = 0.947, P < 0.05). Conclusion: Atorvastatin down-regulates LPS-induced expression of the COX-2 and consequently inhibits production of PGE2 in cultured A549 cells.

Original languageEnglish (US)
JournalRespiratory Research
Volume6
DOIs
StatePublished - Apr 3 2005
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Lipopolysaccharides
Dinoprostone
Epithelial Cells
Lung
Messenger RNA
Atorvastatin Calcium
Cultured Cells
Proteins
Down-Regulation
Western Blotting
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction

Keywords

  • Atorvastatin
  • Cyclooxygenase-2
  • Human pulmonary epithelial cell
  • Lipopolysaccharide
  • Prostaglandin E

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells. / Wu, Shang Jie; Duan, Shu; Zhao, Shui Ping; Cai, Ying; Chen, Ping; Fang, Xiang.

In: Respiratory Research, Vol. 6, 03.04.2005.

Research output: Contribution to journalArticle

@article{4f31eea30d504a1fb68cdf0e082c82f5,
title = "Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells",
abstract = "Objective: To explore the effects of atorvastatin on expression of cyclooxygenase-2 (COX-2) in human pulmonary epithelial cells (A549). Methods: A549 cells were incubated in DMEM medium containing lipopolysaccharide (LPS) in the presence or absence of atorvastatin. After incubation, the medium was collected and the amount of prostaglandin E2 (PGE2) was measured by enzyme-linked immunosorbent assay (ELISA). The cells were harvested, and COX-2 mRNA and protein were analyzed by RT-PCR and western-blot respectively. Results: LPS increased the expression of COX-2 mRNA and production of PGE2 in a dose- and time-dependent manner in A549. Induction of COX-2 mRNA and protein by LPS were inhibited by atorvastatin in a dose-dependent manner. Atorvastatin also significantly decreased LPS-induced production of PGE2. There was a positive correlation between reduced of COX-2 mRNA and decreased of PGE2 (r = 0.947, P < 0.05). Conclusion: Atorvastatin down-regulates LPS-induced expression of the COX-2 and consequently inhibits production of PGE2 in cultured A549 cells.",
keywords = "Atorvastatin, Cyclooxygenase-2, Human pulmonary epithelial cell, Lipopolysaccharide, Prostaglandin E",
author = "Wu, {Shang Jie} and Shu Duan and Zhao, {Shui Ping} and Ying Cai and Ping Chen and Xiang Fang",
year = "2005",
month = "4",
day = "3",
doi = "10.1186/1465-9921-6-27",
language = "English (US)",
volume = "6",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells

AU - Wu, Shang Jie

AU - Duan, Shu

AU - Zhao, Shui Ping

AU - Cai, Ying

AU - Chen, Ping

AU - Fang, Xiang

PY - 2005/4/3

Y1 - 2005/4/3

N2 - Objective: To explore the effects of atorvastatin on expression of cyclooxygenase-2 (COX-2) in human pulmonary epithelial cells (A549). Methods: A549 cells were incubated in DMEM medium containing lipopolysaccharide (LPS) in the presence or absence of atorvastatin. After incubation, the medium was collected and the amount of prostaglandin E2 (PGE2) was measured by enzyme-linked immunosorbent assay (ELISA). The cells were harvested, and COX-2 mRNA and protein were analyzed by RT-PCR and western-blot respectively. Results: LPS increased the expression of COX-2 mRNA and production of PGE2 in a dose- and time-dependent manner in A549. Induction of COX-2 mRNA and protein by LPS were inhibited by atorvastatin in a dose-dependent manner. Atorvastatin also significantly decreased LPS-induced production of PGE2. There was a positive correlation between reduced of COX-2 mRNA and decreased of PGE2 (r = 0.947, P < 0.05). Conclusion: Atorvastatin down-regulates LPS-induced expression of the COX-2 and consequently inhibits production of PGE2 in cultured A549 cells.

AB - Objective: To explore the effects of atorvastatin on expression of cyclooxygenase-2 (COX-2) in human pulmonary epithelial cells (A549). Methods: A549 cells were incubated in DMEM medium containing lipopolysaccharide (LPS) in the presence or absence of atorvastatin. After incubation, the medium was collected and the amount of prostaglandin E2 (PGE2) was measured by enzyme-linked immunosorbent assay (ELISA). The cells were harvested, and COX-2 mRNA and protein were analyzed by RT-PCR and western-blot respectively. Results: LPS increased the expression of COX-2 mRNA and production of PGE2 in a dose- and time-dependent manner in A549. Induction of COX-2 mRNA and protein by LPS were inhibited by atorvastatin in a dose-dependent manner. Atorvastatin also significantly decreased LPS-induced production of PGE2. There was a positive correlation between reduced of COX-2 mRNA and decreased of PGE2 (r = 0.947, P < 0.05). Conclusion: Atorvastatin down-regulates LPS-induced expression of the COX-2 and consequently inhibits production of PGE2 in cultured A549 cells.

KW - Atorvastatin

KW - Cyclooxygenase-2

KW - Human pulmonary epithelial cell

KW - Lipopolysaccharide

KW - Prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=25444463807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444463807&partnerID=8YFLogxK

U2 - 10.1186/1465-9921-6-27

DO - 10.1186/1465-9921-6-27

M3 - Article

VL - 6

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

ER -